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Abstract
Objective: Cognitive-behavioural therapy (CBT) is an efficacious and effective
treatment for eating disorders, and is particularly valuable in the treatment of
non-underweight cases (e.g., bulimia nervosa; binge eating-disorders). How-
ever, its recommended length for such cases (up to 20 sessions) makes it a rela-
tively costly therapy. It has been suggested that a 10-session version (CBT-T)
can also be effective, but there has been no direct comparison between the two
forms (10 vs. 20 sessions).
Method: This study reports the outcomes of brief and standard-length CBT
for non-underweight eating disorders, comparing two cohorts of patients from
the same clinic (N = 55 and 138, respectively).
Results: The two therapies had very similar results in terms of eating pathol-
ogy, remission rate, and improved quality of life. Each showed substantial
change by the mid-point of therapy and up to 6-month follow-up.
Conclusion: It appears that brief CBT (CBT-T) is as effective as existing
20-session CBT, and is less demanding of time and resource. The findings need
to be replicated in a randomized control trial before this conclusion can be
made definitive.
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1 | INTRODUCTION
Cognitive-behavioural therapy for eating disorders (CBT-
ED) is the most effective psychotherapeutic approach for
patients with non-underweight conditions, such as
bulimia nervosa and binge-eating disorder (National Insti-
tute for Health and Care Excellence [NICE] 2017). How-
ever, when delivered individually (at a recommended
16–20 sessions; NICE 2017), it is relatively expensive and
demanding of resources. Reducing the length of CBT-ED
has the potential to reduce waiting lists and ensure faster
access to treatment for other patients. However, that is
only a viable approach if the briefer version has compara-
ble outcomes and acceptability to patients. It has been
shown that anxiety disorders respond to brief versions of
CBT as well as longer versions (Öst & Ollendick, 2017), so
the question here is whether that same pattern can be
found with non-underweight eating disorders.
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A recent innovation has been the development of a
briefer, more focused form of CBT-ED for non-
underweight eating disorders (Waller, Turner, Tatham,
Mountford, & Wade, 2019). This 10-session approach
(CBT-T) is based around core, evidence-based elements
of CBT-ED (e.g., focus on early change) and relatively
novel methods from the field of CBT (e.g., an inhibitory
learning approach to exposure; Craske, Treanor, Conway,
Zbozinek, & Vervliet, 2014; Reilly, Anderson, Gorrell,
Schaumberg, & Anderson, 2017). Initial case series have
demonstrated that CBT-T is an effective approach
(Pellizzer, Waller, & Wade, 2019a, 2019b; Waller
et al., 2018). Outcomes from the first case series (Waller
et al., 2018) indicated levels of effectiveness in routine
clinical settings that were comparable to those of existing,
longer forms of CBT-ED, such as enhanced CBT (CBT-E;
Byrne, Fursland, Allen, & Watson, 2011; Fairburn
et al., 2009). However, that comparison was across stud-
ies and settings, so could not provide firm conclusions.
Consequently, it is important to directly compare out-
comes of a current NICE-recommended version of CBT-
ED with briefer CBT-ED, delivered in the same clinical
setting. If the outcomes of CBT-T can be shown to be
similar to those of longer forms of CBT-ED (in this
instance, CBT-E), then briefer therapies should be con-
sidered as a viable option, with the potential additional
benefits of reducing waiting times and lowering the costs
of treatment.
The aim of this study was to compare the outcomes
of CBT-E and CBT-T for non-underweight eating disor-
ders, to determine whether the additional therapy
input (20 vs. 10 sessions) results in stronger outcomes
for CBT-E. This cohort comparison was conducted in a
routine clinical setting, where attrition rates are usu-
ally somewhat higher than in research settings but
where outcomes are generally comparable when deliv-
ering the therapy in concordance with the protocol




This study compared outcomes of non-underweight
eating disorder patients who were offered and com-
menced either CBT-E (N = 138) or CBT-T (N = 55).
Intention to treat analyses were used. Ethical approval
was not required under National Health Service
guidelines as this was an audit of routine clinical
practice.
2.2 | Participants
The 193 patients who commenced treatment were all
adults (aged ≥18 years) diagnosed with an eating disorder
at assessment, using DSM-5 criteria (American Psycho-
logical Association, 2013). All had a measured body mass
index (BMI) of ≥18.5 at the start of treatment. Initially
(February 2011–May 2013), all patients were allocated
to CBT-E (N = 54), until CBT-T was introduced as an
additional treatment option by the service. Thereafter
(May 2013–June 2019), allocation was decided by clini-
cal team decision, with 84 being allocated to CBT-E
and 55 to CBT-T. Those decisions were made on the
basis of psychiatric and medical risk. Those patients
with higher psychiatric or medical risk were allocated
to the longer 20-session treatment, which was deliv-
ered by staff holding responsibility for case manage-
ment. Lower-weight patients were also more likely to
be allocated to CBT-E, as potentially needing longer to
ensure weight regain.
Among the 138 who received CBT-E (122 women,
14 men), 42 were diagnosed with atypical anorexia
nervosa, 54 with bulimia nervosa, 26 with atypical
bulimia nervosa, 16 with binge-eating disorder, and
two with purging disorder. Among the 55 CBT-T
patients (52 women, three men), three were diagnosed
with atypical anorexia nervosa, 32 with bulimia
nervosa, 12 with atypical bulimia nervosa, eight with
binge-eating disorder, and none with purging disorder.
A Chi-squared test (X2 = 15.9, p < .02) showed that a
significantly greater proportion of atypical anorexia
nervosa patients were allocated to CBT-E. However,
there was no association of patient gender and therapy
allocation (X2 = 1.13, NS).
2.3 | Measures and procedure
Patients were weighed (openly) weekly and their height
was measured in order to calculate their BMI. The num-
ber of sessions delivered was recorded for those patients
who completed therapy. Each patient completed the fol-
lowing measures at the specified points.
Eating Disorders Examination-Questionnaire (EDE-Q
version 6; Fairburn, 2008). The EDE-Q Global score was
used to measure levels of eating pathology at the start of
therapy, at the middle of therapy (Session 4 for CBT-T;
Session 10 for CBT-E), at the end of therapy and at
6-month follow-up. The EDE-Q has acceptable psycho-
metric and clinical properties (Berg, Peterson, Frazier, &
Crow, 2012). Based on a score of the non-clinical mean
+ 1 SD, a reduction to below a cut-off score of <2.77 was
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used to indicate a non-clinical level of eating pathology
by the end of therapy and at follow-up.
Clinical Impairment Assessment (CIA; Fairburn,
2008). The CIA was used as an index of quality of life. It
was administered at the beginning and end of therapy
and at 6-month follow-up. The CIA has strong psycho-
metric properties and clinical validity (Fairburn 2008).
2.4 | Interventions
All patients were seen weekly, for 50–60 min sessions.
The CBT-T intervention was introduced to the service
more recently than CBT-E (see above), explaining the
unbalanced numbers across groups.
CBT-E (Fairburn, 2008) is a manualised, evidence-
based treatment for eating disorders. In keeping with rec-
ommendations for non-underweight cases, 20 sessions
were offered. However, they were delivered weekly
throughout, rather than at an increased dose for the first
weeks as recommended in the manual. The therapists
delivering the treatment were either qualified clinical psy-
chologists, counselling psychologists or accredited cognitive
behaviour therapists, and all had attended the relevant
training in CBT-E. Each therapist was supervised weekly,
though there were no adherence checks throughout the
therapy.
CBT-T (Waller et al., 2019) is also a manualised,
evidence-based treatment, designed specifically for non-
underweight eating disorders. Ten weekly sessions were
offered. The therapists delivering the treatment were
assistant psychologists, who had not completed clinical
training. They were trained and supervised (weekly) by
the team who developed the therapy. Again, there were
no adherence checks during the therapy.
2.5 | Data analysis
Data were collected at start of therapy, mid-therapy, end of
therapy and at 6-month follow-up. SPSS (v.25) was used for
all analyses. The CBT-E and CBT-T groups were compared at
the outset of therapy, using independent t-tests, and pre-
treatment predictors of attrition from each group were tested
using binomial logistic regression. Outcomes were compared
using both completer analyses and intention to treat analyses.
The completer analyses used repeated measures ANOVAs
with post hoc Least Significant Difference [LSD] tests, and
with partial eta2 effect sizes). The intention to treat analyses
used multiple imputation (10 imputations) to replace missing
data, and paired t-tests were used to compare scores within
groups at different time points (with Cohen's d used to deter-
mine effect sizes). Multiple regression analyses were used to
determine whether length of treatment was associated with
outcome levels for each therapy separately.
3 | RESULTS
3.1 | Pre-treatment group characteristics
Table 1 shows the characteristics of each group at the
outset of treatment. The groups' scores were comparable
to those of other clinical groups (Turner et al., 2015). The
group who received CBT-T had a significantly higher
BMI score at the outset of therapy, potentially due to the
greater likelihood of atypical anorexia nervosa cases
being allocated to CBT-E. However, there were no signifi-
cant differences in age, EDE-Q Global score, CIA score,
or personality disorder features.
3.2 | Attrition rates and treatment dose
Of the 138 patients who undertook CBT-E, 86 (62.3%)
were lost to therapy (higher than the 50% reported by
Byrne et al., 2011). Of those 86, 37 terminated by mutual
agreement, 40 dropped out without warning or agree-
ment, and nine moved out of area during therapy and
were unable to continue. Mutual agreement to terminate
was defined as the patient and therapist agreeing that the
treatment was not suitable at present, either because the
patient was not progressing, because the patient and ther-
apist did not find the therapy suitable, or because other
priorities had emerged in life that meant that the patient
did not have the time to dedicate to the therapy. Some
cases were offered alternative treatment approaches
(e.g., an integrative approach, or treatment that was more
geared to risk management), but most were offered the
chance to return when they felt more able to commit to
change. Any cases where the patient and therapist con-
sidered that the therapy had been effective early on were
considered to have completed therapy, and were offered
the regular follow-up.
Of the 55 patients who started CBT-T, 24 (47.3%) were
lost to therapy (9 terminated by mutual agreement
[as defined above], 14 dropped out, and 3 moved area). A
chi-squared test showed that the pattern of reasons for
attrition did not differ between therapies (X2 = 4.17,
df = 3, NS). The mean number of sessions for the patients
who remained in therapy was 17.4 (SD = 9.46) for those
who completed CBT-E and 9.76 (SD = 1.46) for those who
completed CBT-T, in keeping with the planned duration
of each therapy.
Binomial logistic regressions were used to deter-
mine whether there were any initial characteristics
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(age, BMI, EDE-Q score, CIA score) that predicted
treatment completion in either form of CBT. For
CBT-E, there was an overall effect (chi-squared = 10.4,
p = .035), which was related only to BMI (B = 0.081,
p = .06), showing that those with a higher BMI were
more likely to complete treatment. For CBT-T, there
was no significant overall effect, and none of the indi-
vidual predictors approached significance. Therefore, it
appears that the lower mean BMI in the CBT-E group
(see Tables 2 and 3) was associated with their greater
level of attrition.
3.3 | Clinical outcomes of CBT-E and
CBT-T
Table 2 shows the results of completer analyses for
each of the two groups, comparing scores on the
EDE-Q Global scale and BMI at the start of therapy,
the midpoint (Session 4 for CBT-T; Session 10 for
CBT-E), the end of therapy, and the 6-month follow-
up. It also shows the groups' CIA scores across ther-
apy (start, end and follow-up). The changes over time
are tested using repeated measure ANOVAs, with
TABLE 1 Group characteristics at the outset of each version of CBT for patient with non-underweight eating disorders
Form of CBT-ED
CBT-E (N = 138) CBT-T (N = 55) t-test
M (SD) M (SD) t P
Age (years) 31.5 (12.4) 29.4 (10.2) 1.08 NS
Body mass indexa 25.7 (8.62) 29.3 (11.9) 1.99 .05
Eating disorders examination-questionnaire global
score
4.36 (1.11) 4.39 (1.06) 0.18 NS
Clinical impairment assessment 33.7 (10.2) 29.8 (5.32) 0.78 NS
aUnequal variances assumed.
TABLE 2 Levels of eating pathology at each measurement point for non-underweight patients undertaking 20-session CBT for eating
















CBT-E M 4.22 3.38 2.13 2.42 6.62 .007 0.623 Start > end = FU
(SD) (0.82) (1.78) (1.29) (1.52)
CBT-T M 4.10 3.11 2.08 2.02 31.6 .001 0.637 Start > mid > end = FU
(SD) (1.29) (1.51) (1.42) (1.57)
BMI
CBT-E M 27.7 28.0 29.6 29.7 4.85 .005 0.222 Start = mid < end = FU
(SD) (11.1) (11.7) (13.1) (12.9)
CBT-T M 32.4 32.6 33.0 33.0 3.44 .038 0.352 Start = mid < end = FU
(SD) (13.1) (13.5) (13.3) (13.3)
CIA
CBT-E M 28.0 - 12.8 18.4 12.8 .002 0.741 Start > FU > end
(SE) (12.6) (10.3) (12.9)
CBT-T M 27.3 - 17.0 20.1 9.43 .008 0.566 Start > end > FU
(SE) (6.92) (20.0) (15.7)
Note: Comparisons are made using repeated measures ANOVAs, using completer analysis. Partial eta2 is used to determine effect sizes.
Abbreviations: BMI, body mass index; CIA, Clinical Impairment Assessment; EDE-Q, Eating Disorders Examination-Questionnaire.
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TABLE 3 Levels of eating pathology at each measurement point for non-underweight patients undertaking 20-session CBT for eating disorders (CBT-E; N = 138) or 10-session CBT for
eating disorders (CBT-T; N = 55)
Measurement point Start to mid Start to end End to FU
EDE-Q Global Start of therapy Mid therapy End of therapy Follow-up t d (95% CI) t d (95% CI) t d (95% CI)
CBT-E M 4.42 3.50 2.40 2.49 2.62* 0.39 12.1*** 1.44 0.44 0.06
(SE) (0.11) (0.28) (0.14) (0.15) (0.23–0.54) (1.17–1.72) (−0.19–0.30)
CBT-T M 4.44 3.61 2.40 2.45 2.46* 0.44 9.72*** 1.26 0.15 −0.03
(SE) (0.21) (0.27) (0.22) (0.24) (0.16–0.74) (0.91–1.64) (−0.46–0.40)
BMI
CBT-E M 25.7 25.9 25.1 25.8 0.78 0.02 0.08 0.09 0.54 0.10
(SE) (0.73) (0.77) (0.85) (0.60) (−0.06–0.01) (−0.12–0.29) (−0.14–0.33)
CBT-T M 31.9 32.2 32.7 32.4 1.19 0.02 0.12 0.05 0.31 0.02
(SE) (2.25) (2.31) (2.29) (2.29) (−0.04–0.01) (−0.31–0.21) (−0.31–0.35)
CIA
CBT-E M 33.8 - 15.9 19.3 - - 10.5*** 1.36 4.97*** 0.54
(SE) (1.57) (0.56) (0.56) (1.10–1.64) (0.36–0.74)
CBT-T M 33.5 - 16.1 19.4 - - 9.72*** 0.92 0.15 0.41
(SE) (3.30) (0.96) (1.17) (0.56–1.29) (0.14–0.69)
Note: Comparisons are paired t-tests, using intention to treat analyses. Cohen's d is used to determine effect sizes for significant differences.












multiple comparison LSD tests. Table 3 shows the
same comparisons for intention to treat analyses
(multiple imputation). In this case, paired t-tests were
used to compare scores across the different time
points.
The pattern of changes was very similar across the
two forms of analysis. EDE-Q scores reduced across the
course of therapy, with large changes, and the improve-
ment was maintained into follow-up. CIA scores reduced
substantially across treatment, with some rise during
follow-up. While BMI scores rose slightly over the latter
part of each form of CBT, this was only significant in the
completer analyses.1
3.4 | Remission
Remission was defined as a reduction in EDE-Q scores
from above to below a cut-off of 2.77 (Turner et al., 2015).
At the end of therapy, 61.2% of the patients who had
undertaken CBT-E had an EDE-Q Global score that had
fallen to below the cut off (<2.77), while 58.6% of the
CBT-T patients had fallen to below that level. At follow-
up, those figures were 58.6 and 59.3%, respectively. These
outcomes indicate comparable levels of remission for the
two therapies.
3.5 | Impact of number of sessions of
CBT-E and CBT-T
As noted above, the two therapies were of the expected
duration (number of sessions), but CBT-E had a wider var-
iance in number of sessions. While CBT-T can vary in
length, that is recommended only when the full 10 sessions
are not needed. Therefore, it is possible that the duration
of each of the two therapies was associated with the level
of change in eating pathology. In order to test this possibil-
ity, stepwise multiple regression analyses (intention to
treat) were used to test whether the number of CBT-ED
sessions predicted outcome on the end of treatment and
follow-up EDE-Q Global scores, once the start of treat-
ment EDE-Q Global score was accounted for in each case.
At the end of CBT-E treatment, there was no overall
effect of either the initial EDE-Q Global score (t = 0.44,
NS) or the number of sessions (t = 0.65, NS). Similarly,
there were no effects of either initial variable at the
6-month follow-up point (t = 1.05, NS and t = 0.18, NS,
respectively). In contrast, for CBT-T at the end of treat-
ment, there was an effect of initial EDE-Q Global score
(t = 2.59, p < .001, B = .511) though not for the number
of sessions (t = 0.77, NS). There were no such effects for
either therapy by the 6-month follow-up.
4 | DISCUSSION
This study has compared clinical outcomes from two
forms of CBT-ED for non-underweight patients with eat-
ing disorders, to determine whether or not the longer ver-
sion (CBT-E; 20 sessions) has stronger outcomes than the
shorter version (CBT-T; 10 sessions). The two forms of
CBT-ED had very similar outcomes to each other, as well
as to those found in the wider literature (Byrne
et al., 2011; Fairburn et al., 2009; Pellizzer et al., 2019a;
Pellizzer et al., 2019b; Turner et al., 2015; Waller
et al., 2018). EDE-Q scores fell significantly between the
beginning, middle and end of therapy, and remained low
at 6-month follow-up, with mean levels below the
suggested clinical cut-off for approximately 60% of the
patients. It is also noteworthy that CBT-T achieved
the same impact in its first four sessions as CBT-E
achieved in the first 10 sessions, stressing the importance
of achieving meaningful early change, regardless of
the overall length of therapy (Vall & Wade, 2015). There
were parallel improvements in quality of life (CIA scores)
through to the end of CBT-ED, with a partial loss of gains
at the 6-month follow-up. There was no impact of treat-
ment dose in either form of therapy. Patients in the
CBT-T group tended to be less likely to drop out of ther-
apy, but it is likely that any such difference was due to
CBT-E being a longer therapy, therefore providing more
opportunities to leave therapy.
To summarise, in a routine clinical group of non-
underweight patients, CBT-ED was as effective in 10 ses-
sions (CBT-T) as in 20 (CBT-E). Therefore, it appears to
be feasible to offer the majority of adult patients with eat-
ing disorders (i.e., non-underweight cases - Fairburn &
Harrison, 2003) a treatment that is more time-limited
and efficient than current evidence-based options, with-
out loss of effectiveness. To have such briefer therapies
available means that patient turnover can be improved,
allowing services to reduce waiting times while continu-
ing to deliver effective, manualised and evidence-based
therapy (Fukutomi et al., 2019). Furthermore, the cost
savings afforded by a shorter therapy that can be deliv-
ered by supervised assistants (rather than more expensive
qualified therapists) allows more patients to be offered
effective treatment.
This study has two linked methodological issues that
should be addressed in future studies. The first is that the
missing data could not be considered to be missing
completely at random. Multiple imputation analysis was
used to correct for those missing data (Rubin, 1987), to
overcome the problems of listwise loss of data or of single
imputation methods (e.g., the last number carried for-
ward method). Such an approach to missing data should
be used in similar research in the future. The second
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linked issue is the limitation due to the use of repeated-
measures ANOVAs. This form of analysis corrects for the
non-independence of data (due to the same patient con-
tributing multiple data points). However, those methods
of making corrections are limited, particularly because
they assume that any missing data are missing at
random—an assumption that could not be supported (see
above). Provided the sample is large enough, future
research in this field should consider the use of data ana-
lytic methods that are not limited in this way—
particularly hierarchical linear models (Verbeke &
Molenberghs, 2001).
Furthermore, the non-randomized nature of this study
means that further work is needed, in the form of
randomised control trials. Such work should also consider
whether there are patient or therapist factors that may
result in CBT-E being a more effective approach than
CBT-T or vice versa, though such factors could not be iden-
tified in this study. A further question is whether other
evidence-based therapies for eating disorders and for under-
weight eating disorders (Lock & Le Grange, 2013; Schmidt
et al., 2015) are also capable of delivering more rapid out-
comes if presented in a shorter, more focused form.
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1 These analyses were re-run for the CBT-E group, removing the
atypical anorexia nervosa cases, in order to determine whether
those cases influenced the outcomes for this form of CBT. How-
ever, the outcomes were unchanged, indicating that the impact of
CBT-E overall was not affected by the unequal allocation of the
atypical anorexia nervosa cases. As there were so few atypical
anorexia nervosa cases in the CBT-T group, this check could not
be conducted for that group.
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